Aptamer-Modified Polymer Foam for Specific Growth Factor Binding
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Negative pressure wound therapy lacks specificity in binding proteins, often failing to differentiate between harmful and beneficial factors, leading to inefficient delivery and retention of growth factors at the wound site.
Innovation Solution
Development of aptamer-modified polymers, such as those with a polypeptide sequence like GHQGQHIGQMS, covalently attached to a polymer foam via linkers like EMCS or silyl derivatives, which can specifically bind and retain growth factors like GM-CSF and VEGF, enhancing their delivery and retention at the wound site.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If conventional coatings (collagen, PVA, PEG, fibrinogen) are used to bind proteins in wound therapy, then the binding is achieved, but the binding lacks specificity and cannot differentiate between harmful and beneficial factors
Solution Approach 1:
The patent applies local quality by introducing specific functional groups (hydroxyl, carboxyl, amine) at specific locations on the polymer coating, which can selectively bind to target proteins through covalent attachment. This localized functionalization enables the coating to differentiate between harmful and beneficial factors by creating specific binding sites rather than uniform non-specific binding across the entire coating surface.
Solution Approach 2:
The patent employs composite materials by combining polymer coatings with specific binding moieties (hydroxyl, carboxyl, amine groups) to create a multi-functional coating system. This composite approach allows the coating to simultaneously provide structural integrity (from the polymer matrix) and specific protein binding capability (from the functional groups), resolving the contradiction between reliability and complexity.
2Reliability
If non-covalent binding is used for protein attachment, then the coating is easier to apply, but the binding lacks stability and target specificity
Solution Approach 1:
The patent applies preliminary action by pre-installing reactive functional groups (hydroxyl, carboxyl, amine) on the polymer coating during the coating formation process. These pre-positioned groups are then activated to form covalent bonds with target proteins, ensuring stable and specific binding. This preliminary preparation eliminates the need for complex post-application modification steps, maintaining ease of manufacture while achieving reliable binding.
3Reliability
If proteins are bound without specific orientation, then the binding process is simpler, but the active site function is not retained
Solution Approach 1:
The patent applies local quality by creating specific binding pockets or regions on the polymer coating surface that are chemically tailored to recognize and bind to specific epitopes or domains on target proteins. This localized chemical recognition ensures that proteins are bound in a specific orientation that preserves active site functionality, while the rest of the coating maintains its simplified structure.
Solution Approach 2:
The patent uses intermediary molecules or functional groups (such as hydroxyl, carboxyl, or amine groups) that act as mediators between the polymer coating and the target protein. These intermediaries provide specific interaction sites that guide the protein into the correct orientation, ensuring active site functionality without requiring complex direct binding mechanisms.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The aptamer-modified polymers effectively capture and retain specific growth factors, improving their availability and activity at the wound site, thereby accelerating tissue growth and healing.
Implementation Method 1
aptamer (e.g., polypeptide) modified polymers, which may be used for the binding of factors, such as from a wound bed
Implementation Method 2
polymer foam substrate conjugated to a polypeptide
Data Source
AI summary
Aptamer-modified polymers and materials thereof, used for binding factors in a wound bed. The aptamer-modified materials can be polypeptides conjugated to polymer foam materials and used, for example, as dressings, wound inserts, or pads.